Purpose of Review
Endoscopic screening and surveillance for Barrett’s esophagus (BE) as well as treatment of dysplastic BE is well established. A significant proportion of BE patients are older (geriatric age group, > 65 years age). There is relatively little information or recommendations in the literature with regards to evaluation and management of geriatric BE patients. The purpose of this review is to outline specific caveats and best practice recommendations to help manage the geriatric BE patient.
In this review, we have attempted to summarize the latest evidence and guideline-based recommendations for evaluation and treatment of BE and early esophageal neoplasia, with a special focus on the challenges and considerations involved when caring for the geriatric BE patient. Concepts related to sedation, endoscopy, risk-benefit assessment, and other unique issues pertaining to the older BE patient are discussed. Expert recommendations are provided wherever possible.
This review highlights the importance of recognizing the unique aspects of evaluating and managing the geriatric BE patient. Practical recommendations are discussed which will help the provider individualize and optimize care for their geriatric BE patient.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Shaheen NJ, Falk GW, Iyer PG, Gerson LB, American College of Gastroenterology. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016;111(1):30–50 quiz 51. (Recent ACG practice guideline, practical evidence based recommendations).
• Iyer PG, Kaul V. Barrett esophagus. Mayo Clin Proc. 2019;94(9):1888–901 (Very recent comprehensive review of BE evaluation and management).
Howlader N NA, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Accessed.
Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, et al. The effect of endoscopic surveillance in patients with Barrett's esophagus: a systematic review and meta-analysis. Gastroenterology. 2018;154(8):2068–86 e2065.
Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):390–405.
Kurin M, Fass R. Management of gastroesophageal reflux disease in the elderly patient. Drugs Aging. 2019;36(12):1073–81.
Dumic I, Nordin T, Jecmenica M, et al. Gastrointestinal tract disorders in older age. Can J Gastroenterol Hepatol. 2019;2019:6757524.
Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63(1):7–42.
American Gastroenterological A, Spechler SJ, Sharma P, et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011;140(3):1084–91.
• Qumseya B, Sultan S, ASGE SOP Committee, et al. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019;90(3):335–59 e332. (Very recent ASGE updated guidelines for BE manageemnt).
Ko MS, Fung KZ, Shi Y, Espaldon R, Shergill A, Walter LC. Barrett's esophagus commonly diagnosed in elderly men with limited life expectancy. J Am Geriatr Soc. 2016;64(10):e109–11.
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706–15.
Nochaiwong S, Ruengorn C, Awiphan R, Koyratkoson K, Chaisai C, Noppakun K, et al. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018;33(2):331–42.
Singh S, Garg SK, Singh PP, Iyer PG, el-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014;63(8):1229–37.
Bresalier RS. Chemoprevention of Barrett's esophagus and esophageal adenocarcinoma. Dig Dis Sci. 2018;63(8):2155–62.
Mittal C, Han S, Wani S. Chemoprevention of Barrett's esophagus with nonsteroidal anti-inflammatory drugs. Gastroenterology. 2017;152(6):1615–6.
Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, et al. Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointest Endosc. 2018;87(2):348–55.
Razavi F, Gross S, Katz S. Endoscopy in the elderly: risks, benefits, and yield of common endoscopic procedures. Clin Geriatr Med. 2014;30(1):133–47.
Trindade AJ, Navaneethan U, et al. Advances in the diagnosis and surveillance of Barrett's esophagus (with videos). Gastrointest Endosc. 2019;90(3):325–34.
Wani S, Qumseya B, ASGE SOP Committee, et al. Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018;87(4):907–31 e909.
Terheggen G, Horn EM, Vieth M, Gabbert H, Enderle M, Neugebauer A, et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia. Gut. 2017;66(5):783–93.
Knabe M, Blosser S, Wetzka J, et al. Non-thermal ablation of non-neoplastic Barrett's esophagus with the novel EndoRotor(R) resection device. United Eur Gastroenterol J. 2018;6(5):678–83.
Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88.
Trindade AJ, Inamdar S, Kothari S, Berkowitz J, McKinley M, Kaul V. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus. Dig Endosc. 2017;29(6):680–5.
Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video). Gastrointest Endosc. 2018;88(3):438–46 e432.
Solomon SS, Kothari S, Smallfield GB, Inamdar S, Stein P, Rodriguez VA, et al. Liquid nitrogen spray cryotherapy is associated with less postprocedural pain than radiofrequency ablation in Barrett's esophagus: a multicenter prospective study. J Clin Gastroenterol. 2019;53(2):e84–90.
van Munster SN, Overwater A, Haidry R, Bisschops R, Bergman JJGHM, Weusten BLAM. Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain. Gastrointest Endosc. 2018;88(5):795–803 e792.
Mohan BP, Krishnamoorthi R, Ponnada S, et al. Liquid nitrogen spray cryotherapy in treatment of Barrett's esophagus, where do we stand? A systematic review and meta-analysis. Dis Esophagus. 2019;32(6).
Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK. Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(6):1396–404 e1391.
• Kaul V, Bittner K, Ullah A, et al. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center. Dis Esophagus. 2020; (Very recent comprehensive multimodality endoscopic BE therapy paper).
Acosta RD, Abraham NS, ASGE SOP Committee, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16.
Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, et al. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2015;36(46):3238–49.
Conflict of Interest
Dr. Vivek Kaul is a consultant for Olympus, Medtronic, Cook Medical and CSA Medical, and has received research funding from CSA Medical outside of the submitted work. Sarah Enslin has no COI to report.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Gastroenterology in Geriatric Patients
About this article
Cite this article
Enslin, S., Kaul, V. Barrett’s Esophagus Management in the Elderly: Principles and Best Practice. Curr Gastroenterol Rep 22, 37 (2020). https://doi.org/10.1007/s11894-020-00774-2
- Esophageal cancer
- Endoscopic resection